{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:32:45Z","timestamp":1793313165099,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":28,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence nationale de la recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004784","name":"Novartis Foundation for Medical-Biological Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaci.2026.07.011","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:22:54Z","timestamp":1785367374000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["IL-1 confers IgG-mediated protection against allergic anaphylaxis"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3409-512X","authenticated-orcid":false,"given":"Paul","family":"Engeroff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Belbezier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Vaineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Miguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwladys","family":"Fourcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Vigneron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Tchitchek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Graff-Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Bellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Klatzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2026.07.011_bib1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/nri1958","article-title":"The increase in the prevalence of asthma and allergy: food for thought","volume":"6","author":"Devereux","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib2","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2017.09.005","article-title":"Global issues in allergy and immunology: parasitic infections and allergy","volume":"140","author":"Cruz","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2015.03.048","article-title":"The allergy epidemics: 1870-2010","volume":"136","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib4","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164501","article-title":"Immunotherapy-induced neutralizing antibodies disrupt allergen binding and sustain allergen tolerance in peanut allergy","volume":"133","author":"LaHood","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.07.011_bib5","doi-asserted-by":"crossref","first-page":"3659","DOI":"10.1111\/all.15089","article-title":"Advances and highlights in biomarkers of allergic diseases","volume":"76","author":"Ogulur","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.011_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1339171","article-title":"IgG in the control of Fc\u03b5RI activation: a battle on multiple fronts","volume":"14","author":"Storni","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/all.16248","article-title":"On the role of antibody affinity and avidity in the IgE-mediated allergic response","volume":"80","author":"Bachmann","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.011_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/all.13363","article-title":"Blocking antibodies induced by allergen-specific immunotherapy ameliorate allergic airway disease in a human\/mouse chimeric model","volume":"73","author":"Vizzardelli","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.011_bib9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaci.2023.01.005","article-title":"The role of IgG1 and IgG4 as dominant IgE-blocking antibodies shifts during allergen immunotherapy","volume":"151","author":"Strobl","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib10","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jaci.2011.01.062","article-title":"Facilitated antigen presentation and its inhibition by blocking IgG antibodies depends on IgE repertoire complexity","volume":"127","author":"Holm","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib11","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/all.12327","article-title":"IgG-mediated down-regulation of IgE bound to mast cells: a potential novel mechanism of allergen-specific desensitization","volume":"69","author":"Uerm\u00f6si","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.011_bib12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaci.2010.05.040","article-title":"Mechanisms of allergen-specific desensitization","volume":"126","author":"Uerm\u00f6si","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib13","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1172\/JCI25575","article-title":"IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and Fc\u03b3RIIb cross-linking","volume":"116","author":"Strait","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2026.07.011_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aag1401","article-title":"Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils","volume":"9","author":"Malbec","year":"2016","journal-title":"Sci Signal"},{"key":"10.1016\/j.jaci.2026.07.011_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","article-title":"Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy","volume":"132","author":"Kiel","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib16","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1080\/21645515.2016.1243632","article-title":"Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies","volume":"13","author":"Musa","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jaci.2026.07.011_bib17","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41577-022-00786-1","article-title":"Allergen immunotherapy: past, present and future","volume":"23","author":"Durham","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.590054","article-title":"CpG adjuvant in allergen-specific immunotherapy: finding the sweet spot for the induction of immune tolerance","volume":"12","author":"Montamat","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib19","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/all.14134","article-title":"State-of-the-art in marketed adjuvants and formulations in allergen immunotherapy: a position paper of the European Academy of Allergy and Clinical Immunology (EAACI)","volume":"75","author":"Jensen-Jarolim","year":"2020","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.011_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.molmed.2020.01.007","article-title":"Vaccination against allergy: a paradigm shift?","volume":"26","author":"Bachmann","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.jaci.2026.07.011_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jaci.2015.12.1299","article-title":"Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: lessons from the past and novel mechanisms of action for the future","volume":"137","author":"Valenta","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aan0368","article-title":"Tfr cells lack IL-2R\u03b1 but express decoy IL-1R2 and IL-1Ra and suppress the IL-1\u2013dependent activation of Tfh cells","volume":"2","author":"Ritvo","year":"2017","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1393096","article-title":"Interleukin-1 regulates follicular T cells during the germinal center reaction","volume":"15","author":"Belbezier","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib24","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.188724","article-title":"IL-1\u03b2 signaling modulates T follicular helper and regulatory cells in human lymphoid tissues","volume":"10","author":"Vaineau","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaci.2026.07.011_bib25","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1111\/all.16437","article-title":"IL-1R2 expression in Tfr cells controls allergic anaphylaxis by regulating IgG versus IgE responses","volume":"80","author":"Engeroff","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.011_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/iid3.548","article-title":"Anakinra reduces lung inflammation in experimental acute lung injury","volume":"10","author":"Engeroff","year":"2022","journal-title":"Immun Inflamm Dis"},{"key":"10.1016\/j.jaci.2026.07.011_bib33","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4049\/jimmunol.1501271","article-title":"Low-dose IL-2 induces regulatory T cell\u2013mediated control of experimental food allergy","volume":"197","author":"Bonnet","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib27","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1182\/blood-2025-7278","article-title":"Primary CD34+ derived mast cells provide an excellent platform to assess single agent and combination therapies for mastocytosis","volume":"146","author":"Patel","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2026.07.011_bib28","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/all.13268","article-title":"Allergens displayed on virus-like particles are highly immunogenic but fail to activate human mast cells","volume":"73","author":"Engeroff","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.011_bib29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jim.2014.07.003","article-title":"A novel method to generate and culture human mast cells: peripheral CD34+ stem cell\u2013derived mast cells (PSCMCs)","volume":"413","author":"Schmetzer","year":"2014","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2026.07.011_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jim.2008.04.019","article-title":"Seven week culture of functional human mast cells from buffy coat preparations","volume":"336","author":"Holm","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2026.07.011_bib31","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1111\/all.16090","article-title":"Generation of a virus-like particles based vaccine against IgE","volume":"79","author":"Gharailoo","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2026.07.011_bib32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41590-022-01160-y","article-title":"IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines","volume":"23","author":"Tahtinen","year":"2022","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4049\/jimmunol.167.1.90","article-title":"IL-1 enhances T cell\u2013dependent antibody production through induction of CD40 ligand and OX40 on T cells","volume":"167","author":"Nakae","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib35","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1111\/febs.14467","article-title":"A guide to IL-1 family cytokines in adjuvanticity","volume":"285","author":"Mu\u00f1oz-Wolf","year":"2018","journal-title":"FEBS J"},{"key":"10.1016\/j.jaci.2026.07.011_bib36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2332\/allergolint.10-RAI-0190","article-title":"IL-1 and allergy","volume":"59","author":"Nambu","year":"2010","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaci.2026.07.011_bib37","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jaci.2019.12.007","article-title":"Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens","volume":"145","author":"Storni","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib38","article-title":"Novel adjuvants in allergen-specific immunotherapy: where do we stand?","volume":"15","author":"Lin","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib39","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/stem.140164","article-title":"Interleukin 1 trials in cancer patients: a review of the toxicity, antitumor and hematopoietic effects","volume":"14","author":"Veltri","year":"1996","journal-title":"Stem Cells"},{"key":"10.1016\/j.jaci.2026.07.011_bib40","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jaci.2024.10.033","article-title":"Low-dose IL-2 in birch pollen allergy: a phase-2 randomized double-blind placebo-controlled trial","volume":"155","author":"Rosenzwajg","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102763","article-title":"Interleukin 1\u03b1: a comprehensive review on the role of IL-1\u03b1 in the pathogenesis and treatment of autoimmune and inflammatory diseases","volume":"20","author":"Cavalli","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jaci.2026.07.011_bib43","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature06939","article-title":"Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants","volume":"453","author":"Eisenbarth","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2026.07.011_bib44","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/eji.200838549","article-title":"The Nlrp3 inflammasome is critical for aluminium hydroxide\u2013mediated IL-1\u03b2 secretion but dispensable for adjuvant activity","volume":"38","author":"Franchi","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib45","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230570","article-title":"Landscape of mast cell populations across organs in mice and humans","volume":"220","author":"Tauber","year":"2023","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2026.07.011_bib46","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.3389\/fimmu.2018.01244","article-title":"Tissue-specific expression of the low-affinity IgG receptor, Fc\u03b3RIIb, on human mast cells","volume":"9","author":"Burton","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2172-15-27","article-title":"Interferon-\u03b3 regulates growth and controls Fc\u03b3 receptor expression and activation in human intestinal mast cells","volume":"15","author":"Sellge","year":"2014","journal-title":"BMC Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3389\/fimmu.2014.00254","article-title":"Contribution of human Fc\u03b3Rs to disease with evidence from human polymorphisms and transgenic animal studies","volume":"5","author":"Gillis","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib49","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaci.2007.07.033","article-title":"Anaphylaxis: lessons from mouse models","volume":"120","author":"Finkelman","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2026.07.011_bib50","doi-asserted-by":"crossref","first-page":"12413","DOI":"10.1073\/pnas.1105695108","article-title":"Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis","volume":"108","author":"Khodoun","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaci.2026.07.011_bib51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40629-023-00263-8","article-title":"Anti-allergen monoclonal antibodies for the treatment of allergies","volume":"32","author":"Pengo","year":"2023","journal-title":"Allergo J Int"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926005270?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674926005270?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:54:34Z","timestamp":1793310874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674926005270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":51,"alternative-id":["S0091674926005270"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.011","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IL-1 confers IgG-mediated protection against allergic anaphylaxis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2026.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}